Cocrystal Pharma
COCP | NASDAQ
$1.00
+$0.02 (+2.03%)
At close: Nov 16, 2026, 3:59 PM ET
$1.00
$0.00 (-0.03%)
After-hours:
Nov 16, 2026, 7:50 PM ET
+2.03%
(1D)No price chart data available for 1D timeframe.
Rating
46.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #350/1021 (Top 34%)
Key Statistics
Market Data
Market Cap $19.26M
1D Range
0.96 1.00
52W Range
0.82 1.57
Valuation (TTM)
PE -1.25
PB 18.44
EV/EBITDA -1.86
Valuation (NTM)
Forward PE N/A
Forward PEG 0.14
Price Target $0.00
Cash Flow
FCF Yield -42.3%
SBC Adj. FCF Yield -43.5%
SBC Impact -2.9%
Margins
Gross Margin 100.0%
Operating Margin -3063.6%
FCF Margin -2470.7%
Growth (CAGR)
Revenue 3Y | 5Y 150.0% |
-19.9%
Dil EPS 3Y | 5Y 38.2% |
51.6%
FCF 3Y | 5Y 25.6% |
16.7%
Returns
ROA -213.8%
ROE -207.5%
ROIC -423.9%
Financial Health
Net Cash
$2.17M
Current Ratio 1.24
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based te...
Sector Healthcare
Industry Biotechnology
Employees 10
IPO Date Feb 22, 2012
Website www.cocrystalpharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 13, 2026
EPS
-$0.2
Miss -11.11%
YoY:
-5.26% REV
$105K
Beat 0.00%
Next Earnings
Apr 1, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove COCP